ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 77 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,771,000 | +0.1% | 360,738 | +7.6% | 0.00% | – |
| Q2 2021 | $1,769,000 | +27.9% | 335,106 | +16.2% | 0.00% | – |
| Q1 2021 | $1,383,000 | +102.2% | 288,275 | +82.3% | 0.00% | – |
| Q4 2020 | $684,000 | +5.4% | 158,113 | +0.3% | 0.00% | – |
| Q3 2020 | $649,000 | +61.0% | 157,645 | 0.0% | 0.00% | – |
| Q2 2020 | $403,000 | -52.9% | 157,645 | -46.7% | 0.00% | – |
| Q1 2020 | $855,000 | -62.4% | 295,932 | -50.8% | 0.00% | – |
| Q4 2019 | $2,276,000 | +67.0% | 600,914 | +125.4% | 0.00% | – |
| Q3 2019 | $1,363,000 | -17.0% | 266,555 | +0.6% | 0.00% | – |
| Q2 2019 | $1,642,000 | -4.5% | 264,869 | +9.5% | 0.00% | – |
| Q1 2019 | $1,719,000 | -56.8% | 241,793 | -48.1% | 0.00% | -100.0% |
| Q4 2018 | $3,976,000 | -8.9% | 465,800 | +113.7% | 0.00% | 0.0% |
| Q3 2018 | $4,364,000 | -15.0% | 217,998 | +9.6% | 0.00% | -50.0% |
| Q2 2018 | $5,137,000 | +25.2% | 198,894 | +15.8% | 0.00% | +100.0% |
| Q1 2018 | $4,103,000 | -16.3% | 171,703 | +18.7% | 0.00% | -50.0% |
| Q4 2017 | $4,900,000 | +82.2% | 144,614 | +13.8% | 0.00% | +100.0% |
| Q3 2017 | $2,689,000 | +21.7% | 127,044 | +0.5% | 0.00% | 0.0% |
| Q2 2017 | $2,209,000 | +0.4% | 126,354 | +0.4% | 0.00% | 0.0% |
| Q1 2017 | $2,201,000 | +8.7% | 125,793 | +4.9% | 0.00% | 0.0% |
| Q4 2016 | $2,025,000 | +7.7% | 119,873 | +4.6% | 0.00% | 0.0% |
| Q3 2016 | $1,881,000 | +10.8% | 114,631 | +2.2% | 0.00% | 0.0% |
| Q2 2016 | $1,698,000 | +31.3% | 112,201 | +25.4% | 0.00% | 0.0% |
| Q1 2016 | $1,293,000 | -39.0% | 89,468 | +19.6% | 0.00% | 0.0% |
| Q4 2015 | $2,119,000 | +146.1% | 74,835 | +45.4% | 0.00% | 0.0% |
| Q3 2015 | $861,000 | -33.1% | 51,486 | +4.8% | 0.00% | 0.0% |
| Q2 2015 | $1,287,000 | +73.9% | 49,123 | +16.1% | 0.00% | – |
| Q1 2015 | $740,000 | +8.0% | 42,319 | +7.2% | 0.00% | – |
| Q4 2014 | $685,000 | +109.5% | 39,474 | +124.3% | 0.00% | – |
| Q3 2014 | $327,000 | +2.5% | 17,597 | +0.8% | 0.00% | – |
| Q2 2014 | $319,000 | – | 17,451 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 657,467 | $2,709,000 | 2.82% |
| Healthcare Value Capital, LLC | 100,000 | $412,000 | 1.36% |
| Opaleye Management Inc. | 1,487,800 | $6,130,000 | 1.20% |
| Worth Venture Partners, LLC | 225,106 | $927,000 | 0.76% |
| ARMISTICE CAPITAL, LLC | 2,742,000 | $11,297,000 | 0.41% |
| DELTEC ASSET MANAGEMENT LLC | 355,845 | $1,466,000 | 0.26% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 329,437 | $1,357,000 | 0.19% |
| Mosaic Family Wealth, LLC | 92,357 | $381,000 | 0.14% |
| EMERALD ADVISERS, LLC | 642,226 | $2,646,000 | 0.11% |
| DCF Advisers, LLC | 31,236 | $129,000 | 0.07% |